However, in contrast to the latter, PMD-026 retained its inhibitory function in melanoma cells with acquired resistance to the BRAF inhibitor (R) as well as to a BRAF and MEK inhibitor combination (RR) (Suppl. This evidence concerns the gene BRAF and melanoma.